Comparison between a single dose of PEG G-CSF and multiple doses of non-PEG G-CSF: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022-Reference-Cited by-同舟云学术

Comparison between a single dose of PEG G-CSF and multiple doses of non-PEG G-CSF: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022

Published:2024-04-23 Issue:6 Volume:29 Page:681-688
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Yoshinami Tetsuhiro,Nozawa Kazuki,Yokoe Takamichi,Ozaki Yukinori,Nishio Hiroshi,Tsuchihashi Kenji,Ichihara Eiki,Miura Yuji,Endo Makoto,Yano Shingo,Maruyama Dai,Susumu Nobuyuki,Takekuma Munetaka,Motohashi Takashi,Ito Mamoru,Baba Eishi,Ochi Nobuaki,Kubo Toshio,Uchino Keita,Kimura Takahiro,Kamiyama Yutaro,Nakao Shinji,Tamura Shinobu,Nishimoto Hitomi,Kato Yasuhisa,Sato Atsushi,Takano Toshimi

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s10147-024-02504-4.pdf

Reference29 articles.

1. Crawford J, Caserta C, Roila F et al (2010) Hematopoietic growth factors: ESMO Clinical Practice Guidelines for the applications. Ann Oncol. https://doi.org/10.1093/annonc/mdq195

2. Aapro MS, Bohlius J, Cameron DA et al (2011) 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours. Eur J Cancer. 47(1):8–32. https://doi.org/10.1016/j.ejca.2010.10.013

3. Smith TJ, Bohlke K, Lyman GH et al (2015) Recommendations for the use of WBC growth factors: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol 33(28):3199–3212. https://doi.org/10.1200/JCO.2015.62.3488

4. NCCN Clinical Practice Guidelines in Oncology. Hematopoietic growth factors Version 2. 2023

5. Yang BB, Kido A (2011) Pharmacokinetics and pharmacodynamics of pegfilgrastim. Clin Pharmacokinet 50(5):295–306. https://doi.org/10.2165/11586040-000000000-00000